Contact this trialFirst, we need to learn more about you.
Immunoglobulin
Subcutaneous Immunoglobulin for Myasthenia Gravis
Recruiting2 awardsPhase 2
Toronto, Ontario
This trialwill examine the safety and effectiveness of a new subcutaneous immunoglobulin for treating myasthenia gravis and compare it to existing IVIG treatments.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.